why choose us

First received: March 07, 2024

Clinical Trial: A Study to Evaluate AGN-151586 Intramuscular Injections in Adult Participants for Treatment of Glabellar Lines

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Glabellar Lines

Study Type: INTERVENTIONAL


Official Title: A Phase 3, Multicenter, Randomized, Placebo-Controlled Study of AGN-151586 for the Treatment of Moderate to Severe Glabellar Lines

Brief Summary: Facial lines that develop from repeated facial expression, such as glabellar lines (GL), are typically treated by selectively weakening specific muscles with small quantities of botulinum toxin.The purpose of this study is to evaluate the safety and efficacy of AGN-151586 compared to placebo in adult participants.AGN-151586 is an investigational product being developed for the treatment of GL.In the first period, participants are randomly assigned to receive AGN-151586 or placebo.Each group receives a different…

Read more